Skip to main content

Advertisement

SpringerLink
Log in

Very severe aplastic anemia with papillary thyroid carcinoma: treatment with allo-HSCT—a case report and literature review

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Nalepa G, Clapp DW (2018) Fanconi anaemia and cancer: an intricate relationship. Nat Rev Cancer 18(3):168–185

    Article  CAS  PubMed  Google Scholar 

  2. D’Angelo CR, Novitsky B, Mee Lee S, Godley LA, Kline J, Larson RA, Liu H, Odenike O, Stock W, Bishop MR, Artz AS (2019) Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation. Leukemia Lymphoma 60(3):629–638

    Article  PubMed  Google Scholar 

  3. Smith CC, King AJ (1971) Aplastic anaemia with carcinoma of the thyroid. Postgrad Med J 47(545):161–163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Iannucci A, Perini A, Pizzolo G (2004) Acquired pure red cell aplasia associated with thyroid carcinoma: case report. Acta Haematol 69(1):62–63

    Article  Google Scholar 

  5. Yagasaki H, Inukai T, Uno K, Akahane K, Nakazawa S (2003) Development of severe aplastic anemia in a girl with Hashimoto’s thyroiditis and papillary thyroid carcinoma. Rinsho Ketsueki 44(5):328–333

    PubMed  Google Scholar 

  6. Roskoski R Jr (2020) Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update. Pharmacol Res 152:104609

    Article  CAS  PubMed  Google Scholar 

  7. Schneider TC, Djoeke DW, Links TP, Van ENP, Van DHJJ, Hans G, Roozen ICFM, Manon B, Corver WE, Tom VW (2017) Everolimus in patients with advanced follicular-derived thyroid cancer: results of a phase II clinical trial. J Clin Endocrinol Metab 2:698–707

    Google Scholar 

  8. Hanna GJ, Busaidy NL, Chau NG, Wirth LJ, Barletta JA, Calles A, Haddad RI, Kraft S, Cabanillas ME, Rabinowits G (2018) Genomic correlates of response to everolimus in aggressive radioiodine-refractory thyroid cancer: a phase II study. Clin Cancer Res 2297.2017

Download references

Acknowledgements

The authors are grateful to the patient and his family for their participation.

Funding

This work was supported by Natural Science Foundation of Henan Province (182300410301), Medical Science and Technology Research Project of Henan Province (SBGJ202102147, SBGJ202003036, 2018020118, LHGJ20210298), Science and Technology Plan of Henan Province (182102310160), Project of Higher Education of Henan Province (18A320050).

Author information

Author notes

  1. Jixin Fan, Runqing Lu and Kun Yu contributed equally to this work.

Authors and Affiliations

  1. Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

    Jixin Fan, Runqing Lu, Yinyin Zhang & Rong Guo

  2. Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

    Kun Yu

  3. Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

    Fei He

Authors
  1. Jixin Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Runqing Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kun Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yinyin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fei He
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rong Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.X.F, R.Q.L, and K.Y collected, verified, and interpreted patient information and drafted the manuscript. Y.Y.Z, F.H, and R.G designed the research and critically reviewed and revised the final draft. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Fei He or Rong Guo.

Ethics declarations

Ethics approval and consent to participate

The study was performed in accordance with the guidelines of the Declaration of Helsinki, and informed consent was obtained from the participating patient of the case description.

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, J., Lu, R., Yu, K. et al. Very severe aplastic anemia with papillary thyroid carcinoma: treatment with allo-HSCT—a case report and literature review. Ann Hematol 101, 2809–2811 (2022). https://doi.org/10.1007/s00277-022-05009-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-05009-0

Search

Navigation